Celldex Therapeutics Inc (NASDAQ:CLDX) - Share price - Overview

Stock Report

Celldex Therapeutics Inc CLDX

Last Price
$3.22

Day Change
0.00|0.00%

As of 24/04/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close3.22
Day Range3.17 - 3.25
Mkt Cap406.60Mil
52-Wk Range2.86 - 5.11
Yield %-
ISINUS15117B1035
Volume298,499
P/E-2.54
P/S48.07
P/CF-2.89

Share Price

Financials
201420152016
More ...
Income Statement
Revenue3.595.486.79
Operating Income-122.43-129.54-132.92
Net Income-118.08-127.20-128.53
Basic EPS-1.32-1.31-1.27
Avg. Diluted Shares Outstanding8997102
Balance Sheet
Current Assets204.99294.94195.57
Non Current Assets43.0342.65187.79
Total Assets248.01337.58383.36
Current Liabilities24.4930.2435.22
Total Liabilities36.3547.48117.93
Total Equity211.66290.11265.43
Cash Flow
Operating Cash Flow-101.54-98.89-113.04
Capital Expenditure-1.93-4.88-2.75
Free Cash Flow-103.47-103.76-115.79

In millions, except "Basic EPS". Currency is USD.

Company Profile

Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

210
Key Stats
More ...
Price/Earning TTM-2.54
Price/Book1.49
Price/Sales TTM48.20
Rev Growth (3 year avg)18.18
EPS Growth (3 year avg)-
Operating Margin % TTM-1,958.68
Net Margin % TTM-1,894.05
ROE TTM-46.27
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.